Surrogate_NN
thyroglobulin_NN
receptors_NNS
and_CC
T_NN
cell_NN
proliferation_NN
in_IN
Hashimoto_NN
's_POS
thyroiditis_NN
._.

Immunoglobulin_NN
molecules_NNS
on_IN
the_DT
surface_NN
of_IN
a_DT
B_NN
lymphocyte_NN
are_VBP
the_DT
endogenous_JJ
``_JJ
receptors_NNS
''_NN
to_TO
which_WDT
specific_JJ
antigens_NNS
bind_VBP
._.

Studies_NNS
in_IN
mice_NNS
have_VBP
shown_VBN
that_IN
a_DT
monoclonal_JJ
antibody_NN
,_,
conjugated_VBN
with_IN
palmitate_NN
to_TO
provide_VB
a_DT
lipid_NN
tail_NN
,_,
can_MD
be_VB
inserted_VBN
into_IN
the_DT
cell_NN
membrane_NN
to_TO
provide_VB
a_DT
``_JJ
surrogate_JJ
''_NN
antigen_NN
receptor_NN
._.

We_PRP
have_VBP
investigated_VBN
whether_IN
a_DT
palmitate_JJ
conjugate_NN
of_IN
a_DT
human_JJ
monoclonal_JJ
antibody_NN
specific_JJ
for_IN
thyroglobulin_NN
-LRB-_-LRB-
TG_NN
-RRB-_-RRB-
could_MD
function_VB
as_IN
a_DT
surrogate_JJ
TG_NN
receptor_NN
on_IN
blood_NN
mononuclear_JJ
cells_NNS
separated_VBN
into_IN
fractions_NNS
enriched_VBN
for_IN
T_NN
cells_NNS
or_CC
depleted_VBN
of_IN
T_NN
cells_NNS
-LRB-_-LRB-
non-T_JJ
cells_NNS
-RRB-_-RRB-
._.

Using_VBG
flow_NN
cytometry_NN
,_,
we_PRP
detected_VBD
surrogate_JJ
TG_NN
receptors_NNS
on_IN
non-T_JJ
-LRB-_-LRB-
but_CC
not_RB
on_IN
T_NN
-RRB-_-RRB-
cells_NNS
from_IN
11_CD
of_IN
11_CD
individuals_NNS
studied_VBN
-LRB-_-LRB-
5_CD
Hashimoto_NN
patients_NNS
and_CC
6_CD
control_JJ
donors_NNS
-RRB-_-RRB-
._.

In_IN
contrast_NN
,_,
endogenous_JJ
TG_NN
receptors_NNS
could_MD
only_RB
be_VB
detected_VBN
on_IN
non-T_JJ
cells_NNS
from_IN
1_CD
of_IN
3_CD
Hashimoto_NN
patients_NNS
and_CC
from_IN
0_CD
of_IN
4_CD
control_NN
donors_NNS
._.

Because_IN
of_IN
the_DT
efficient_JJ
binding_NN
of_IN
TG_NN
by_IN
surrogate_JJ
receptors_NNS
on_IN
non-T_JJ
cells_NNS
,_,
we_PRP
assessed_VBD
the_DT
ability_NN
of_IN
such_JJ
cells_NNS
to_TO
present_VB
TG_NN
to_TO
T_NN
cells_NNS
._.

Proliferation_NN
in_IN
response_NN
to_TO
TG_NN
was_VBD
observed_VBN
in_IN
T_NN
cells_NNS
from_IN
only_RB
1_CD
of_IN
5_CD
Hashimoto_NN
patients_NNS
._.

This_DT
low_JJ
frequency_NN
of_IN
response_NN
was_VBD
no_RB
different_JJ
from_IN
that_DT
previously_RB
detected_VBN
using_VBG
cultures_NNS
of_IN
T_NN
cells_NNS
and_CC
autologous_JJ
dendritic_JJ
cells_NNS
._.

Therefore_RB
,_,
the_DT
successful_JJ
generation_NN
of_IN
surrogate_JJ
receptors_NNS
on_IN
non-T_JJ
cells_NNS
is_VBZ
not_RB
associated_VBN
with_IN
more_RBR
efficient_JJ
TG_NN
presentation_NN
of_IN
T_NN
cells_NNS
._.

Furthermore_RB
,_,
the_DT
significance_NN
of_IN
the_DT
present_JJ
study_NN
is_VBZ
that_IN
the_DT
T_NN
cells_NNS
,_,
not_RB
the_DT
antigen-presenting_JJ
cells_NNS
,_,
are_VBP
likely_JJ
to_TO
be_VB
the_DT
limiting_VBG
element_NN
in_IN
the_DT
T_NN
cell_NN
proliferative_JJ
response_NN
to_TO
TG_NN
and_CC
other_JJ
thyroid_NN
autoantigens_NNS
._.

